Invention Grant
- Patent Title: Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases
- Patent Title (中): 用于治疗退行性和炎性疾病的咪唑并吡啶化合物
-
Application No.: US11998818Application Date: 2007-11-30
-
Publication No.: US07951818B2Publication Date: 2011-05-31
- Inventor: Paul John Edwards , Sébastien Laurent Xavier Martina , Martin James Inglis Andrews , Grégory Louis Joseph Bar , Brigitte Allart , Andrew Burritt , Xueliang Tao , Friedrich Erich Karl Kroll
- Applicant: Paul John Edwards , Sébastien Laurent Xavier Martina , Martin James Inglis Andrews , Grégory Louis Joseph Bar , Brigitte Allart , Andrew Burritt , Xueliang Tao , Friedrich Erich Karl Kroll
- Applicant Address: BE Mechelen
- Assignee: Galapagos NV
- Current Assignee: Galapagos NV
- Current Assignee Address: BE Mechelen
- Agency: Klauber & Jackson LLC
- Main IPC: A61K31/44
- IPC: A61K31/44
Abstract:
Novel imidazolopyridine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, ECM degradation, joint degradation and/or inflammation, and others.
Public/Granted literature
- US20090048245A1 Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases Public/Granted day:2009-02-19
Information query
